232 related articles for article (PubMed ID: 17975163)
1. Immunization with mimotopes prevents growth of carcinoembryonic antigen positive tumors in BALB/c mice.
Brämswig KH; Knittelfelder R; Gruber S; Untersmayr E; Riemer AB; Szalai K; Horvat R; Kammerer R; Zimmermann W; Zielinski CC; Scheiner O; Jensen-Jarolim E
Clin Cancer Res; 2007 Nov; 13(21):6501-8. PubMed ID: 17975163
[TBL] [Abstract][Full Text] [Related]
2. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
[TBL] [Abstract][Full Text] [Related]
4. Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes.
Riemer AB; Förster-Waldl E; Brämswig KH; Pollak A; Zielinski CC; Pehamberger H; Lode HN; Scheiner O; Jensen-Jarolim E
Eur J Immunol; 2006 May; 36(5):1267-74. PubMed ID: 16568495
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies.
Riemer AB; Kurz H; Klinger M; Scheiner O; Zielinski CC; Jensen-Jarolim E
J Natl Cancer Inst; 2005 Nov; 97(22):1663-70. PubMed ID: 16288119
[TBL] [Abstract][Full Text] [Related]
6. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein.
Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O
BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122
[TBL] [Abstract][Full Text] [Related]
7. Peptide mimotopes of rabies virus glycoprotein with immunogenic activity.
Houimel M; Dellagi K
Vaccine; 2009 Jul; 27(34):4648-55. PubMed ID: 19520204
[TBL] [Abstract][Full Text] [Related]
8. Molecular mimicry of carcinoembryonic antigen by peptides derived from the structure of an anti-idiotype antibody.
Chatterjee SK; Tripathi PK; Chakraborty M; Yannelli J; Wang H; Foon KA; Maier CC; Blalock JE; Bhattacharya-Chatterjee M
Cancer Res; 1998 Mar; 58(6):1217-24. PubMed ID: 9515808
[TBL] [Abstract][Full Text] [Related]
9. A mimotope of pre-S2 region of surface antigen of viral hepatitis B screened by phage display.
Zhang WY; Wan Y; Li DG; Tang Y; Zhou W
Cell Res; 2001 Sep; 11(3):203-8. PubMed ID: 11642405
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.
Bolesta E; Kowalczyk A; Wierzbicki A; Rotkiewicz P; Bambach B; Tsao CY; Horwacik I; Kolinski A; Rokita H; Brecher M; Wang X; Ferrone S; Kozbor D
Cancer Res; 2005 Apr; 65(8):3410-8. PubMed ID: 15833876
[TBL] [Abstract][Full Text] [Related]
11. Epitope-specific antibody response to HT-1080 fibrosarcoma cells by mimotope immunization.
Popkov M; Sidrac-Ghali S; Alakhov V; Mandeville R
Clin Cancer Res; 2000 Sep; 6(9):3629-35. PubMed ID: 10999755
[TBL] [Abstract][Full Text] [Related]
12. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ
Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319
[TBL] [Abstract][Full Text] [Related]
13. Reduction of human melanoma tumor growth in severe combined immunodeficient mice by passive transfer of antibodies induced by a high molecular weight melanoma-associated antigen mimotope vaccine.
Wagner S; Krepler C; Allwardt D; Latzka J; Strommer S; Scheiner O; Pehamberger H; Wiedermann U; Hafner C; Breiteneder H
Clin Cancer Res; 2008 Dec; 14(24):8178-83. PubMed ID: 19088033
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody against neem leaf glycoprotein recognizes carcinoembryonic antigen (CEA) and restricts CEA expressing tumor growth.
Das A; Barik S; Banerjee S; Bose A; Sarkar K; Biswas J; Baral R; Pal S
J Immunother; 2014 Oct; 37(8):394-406. PubMed ID: 25198527
[TBL] [Abstract][Full Text] [Related]
15. Mimotope vaccination for epitope-specific induction of anti-CD20 antibodies.
Li M; Yan Z; Han W; Zhang Y
Cell Immunol; 2006 Feb; 239(2):136-43. PubMed ID: 16814270
[TBL] [Abstract][Full Text] [Related]
16. Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system.
Lund LH; Andersson K; Zuber B; Karlsson A; Engström G; Hinkula J; Wahren B; Winberg G
Cancer Gene Ther; 2003 May; 10(5):365-76. PubMed ID: 12719706
[TBL] [Abstract][Full Text] [Related]
17. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
Durántez M; López-Vázquez AB; de Cerio AL; Huarte E; Casares N; Prieto J; Borrás-Cuesta F; Lasarte JJ; Sarobe P
Scand J Immunol; 2009 Feb; 69(2):80-9. PubMed ID: 19144076
[TBL] [Abstract][Full Text] [Related]
18. CD20 mimicry by a mAb rituximab-specific linear peptide: a potential tool for active immunotherapy of autoimmune diseases.
Perosa F; Favoino E; Caragnano MA; Dammacco F
Ann N Y Acad Sci; 2005 Jun; 1051():672-83. PubMed ID: 16127008
[TBL] [Abstract][Full Text] [Related]
19. Human monocytes expressing a CEA-specific chimeric CD64 receptor specifically target CEA-expressing tumour cells in vitro and in vivo.
Biglari A; Southgate TD; Fairbairn LJ; Gilham DE
Gene Ther; 2006 Apr; 13(7):602-10. PubMed ID: 16397508
[TBL] [Abstract][Full Text] [Related]
20. A mimotope peptide-based anti-cancer vaccine selected by BAT monoclonal antibody.
Hardy B; Raiter A
Vaccine; 2005 Jul; 23(34):4283-91. PubMed ID: 15919139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]